Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 S

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/10/2026

1. SPY
2. USO
3. META
4. MSFT
5. MU
6. COST
7. IONS
8. CG
9. RXT
10. AAPL

Go back to Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 S
(NASDAQ: BMEA) Delayed: 1.31 +0.01 (0.77%)
Previous Close $1.30    52 Week High $ 
Open $1.31    52 Week Low $ 
Day High $1.35    P/E N/A 
Day Low $1.28    EPS $ 
Volume 757,101